相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1 H -pyrazolo[3,4-b ]quinolines as dual cholinestrase and COX-2 inhibitors
Mohamed Mroueh et al.
BIOORGANIC CHEMISTRY (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents
Mohammad Mahdavi et al.
CHEMISTRY & BIODIVERSITY (2019)
Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease
Hanan M. Ragab et al.
BIOORGANIC CHEMISTRY (2019)
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy
Eva Ramos et al.
MOLECULES (2019)
A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease
Gustavo Provensi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy
Youssef Dgachi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
New semicarbazones as gorge-spanning ligands of acetylcholinesterase and potential new drugs against Alzheimer's disease: Synthesis, molecular modeling, NMR, and biological evaluation
Denise Cristian Ferreira Neto et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
A molecular approach in drug development for Alzheimer's disease
Snezana Agatonovic-Kustrin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives
Chamseddine Derabli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects
Jan Misik et al.
CURRENT ALZHEIMER RESEARCH (2018)
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease
Mourad Chioua et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids
Blanca Colin-Lozano et al.
MOLECULES (2018)
Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
Mourad Chioua et al.
CHEMISTRYSELECT (2018)
Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors
Makbule Ekiz et al.
ARCHIV DER PHARMAZIE (2018)
Synthesis of Novel Tacrine Analogs as Acetylcholinesterase Inhibitors
Mohammad Mahdavi et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2017)
Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation
Eeda Koti Reddy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b] quinoline-3-carboxylates
Mohammad Eghtedari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
Youssef Dgachi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease
Leili Jalili-Baleh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
New (benz) imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease
Houssem Boulebd et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy
Youssef Dgachi et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy
Eva Mezeiova et al.
MOLECULES (2017)
Dihydropyrimidine-Thiones and Clioquinol Synergize To Target beta-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism
Daniel F. Tardiff et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Synthesis and Biological Evaluation of New Tacrine Analogues under Microwave Irradiation
Hossa Fahad Alshareef et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2017)
k Microwave assisted synthesis of novel hybrid tacrine-sulfonamide derivatives and investigation of their antioxidant and anticholinesterase activities
Ramazan Ulus et al.
BIOORGANIC CHEMISTRY (2017)
Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
Ondrej Benek et al.
CHEMMEDCHEM (2016)
Novel Tacrine-Based Pyrano[3′,4′:5,6]pyrano[2,3-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity
Roshanak Hariri et al.
ARCHIV DER PHARMAZIE (2016)
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy
Youssef Dgachi et al.
CHEMMEDCHEM (2016)
Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease
Nuria Garcia-Font et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX
Ladan Pourabdi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Perspectives for the structure-based design of acetylcholinesterase reactivators
Rodrigo Ochoa et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease
Youssef Dgachi et al.
MOLECULES (2016)
Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer 1 s Disease Therapy
Houssem Boulebd et al.
MOLECULES (2016)
Synthesis and biological evaluation of some tacrine analogs: study of the effect of the chloro substituent on the acetylcholinesterase inhibitory activity
Hanan M. Ragab et al.
MONATSHEFTE FUR CHEMIE (2016)
Design, synthesis and evaluation of clioquinol-ebselen hybrids as multi-target-directed ligands against Alzheimer's disease
Zhiren Wang et al.
RSC ADVANCES (2016)
New tetracyclic tacrine analogs containing pyrano[2,3-c]pyrazole: Efficient synthesis, biological assessment and docking simulation study
Mehdi Khoobi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease
Mourad Chioua et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease
Fei Mao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease
Yash B. Joshi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with 'inverted' binding mode
Fouad H. Darras et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine
Guozheng Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease
MG Savelieff et al.
ACS CHEMICAL BIOLOGY (2013)
Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents
Saurabh K. Sinha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent
Gabriel Navarrete-Vazquez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Calcium channel blockers and dementia
V. Nimmrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Structure-Based Search for New Inhibitors of Cholinesterases
Marek Bajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation
Catherine Lambert et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Potassium phthalimide-N-oxyl: a novel, efficient, and simple organocatalyst for the one-pot three-component synthesis of various 2-amino-4H-chromene derivatives in water
Mohammad G. Dekamin et al.
TETRAHEDRON (2013)
A novel hybrid of 6-chlorotacrine and metal-amyloid-beta modulator for inhibition of acetylcholinesterase and metal-induced amyloid-beta aggregation
Akiko Kochi et al.
CHEMICAL SCIENCE (2013)
Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents
Guillaume Mercey et al.
ACCOUNTS OF CHEMICAL RESEARCH (2012)
Understanding Risk Factors for Alzheimer's Disease: Interplay of Neuroinflammation, Connexin-based Communication and Oxidative Stress
Rodrigo A. Quintanilla et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview
Christelle Hureau
COORDINATION CHEMISTRY REVIEWS (2012)
Metal-associated amyloid-β species in Alzheimer's disease
Amit S. Pithadia et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2012)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
Calcium Dysregulation and Homeostasis of Neural Calcium in the Molecular Mechanisms of Neurodegenerative Diseases Provide Multiple Targets for Neuroprotection
Gregor Zuendorf et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Amyloid Clearance as a Treatment Target Against Alzheimer's Disease
Alexander Kurz et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Revisiting the cholinergic in the development of Alzheimer's disease
Laura A. Craig et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
Joshua J. Bornstein et al.
MEDCHEMCOMM (2011)
In vitro antiamyloidogenic properties of 1,4-naphthoquinones
Paloma Bermejo-Bescos et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease
Jan Korabecny et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Cholinesterase inhibitors and memory
Giancarlo Pepeu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Acetylcholinesterase: From 3D structure to function
Hay Dvir et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Plasma Carbonic Anhydrase II protein is Elevated in Alzheimer's Disease
Bong Geom Jang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry
Svetlana B. Tsogoeva
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Roland Jakob-Roetne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Recent Advances in the Identification of γ-Secretase Inhibitors To Clinically Test the Aβ Oligomer Hypothesis of Alzheimer's Disease
Anthony F. Kreft et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Nonsteroidal antiinflammatory drugs: Past, present and future
Carlo Patrono et al.
PHARMACOLOGICAL RESEARCH (2009)
Acetylcholinesterase: How is structure related to function?
Israel Silman et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Huprines for Alzheimer's disease drug development
Diego Munoz-Torrero et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2007)
Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers
Inci Selin Zorkun et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase
Michael Decker
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase:: Binding of bis(5)-tacrine produces a dramatic rearrangement in the active-site gorge
Edwin H. Rydberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase
M Decker et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Molecular basis of interactions of cholinesterases with tight binding inhibitors
Z Radic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology
I Silman et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
CNS targets for multi-functional drugs in the treatment of Alzheimers and Parkinsons diseases
MBH Youdim et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine
M Decker
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
MBH Youdim et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Monoamine oxidase-B inhibition in Alzheimer's disease
P Riederer et al.
NEUROTOXICOLOGY (2004)
12/15-Lipoxygenase is increased in Alzheimer's disease -: Possible involvement in brain oxidative stress
D Praticò et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Neuroprotective effects of (±)-huprine Y on in vitro and in vivo models of excitoxicity damage
AM Canudas et al.
EXPERIMENTAL NEUROLOGY (2003)
β-amyloid aggregation induced by human acetylcholinesterase:: inhibition studies
M Bartolini et al.
BIOCHEMICAL PHARMACOLOGY (2003)
15-lipoxygenase-1: A prooxidant enzyme
T Schewe
BIOLOGICAL CHEMISTRY (2002)
The antioxidant action of Polypodium leucotomos extract and kojic acid:: reactions with reactive oxygen species
AJ Gomes et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)
A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation
GV De Ferrari et al.
BIOCHEMISTRY (2001)
分享论文
